From clinical chemistry to digital pathology: Read more about how modern medical laboratories and procedures in pathology play a vital role in the detection and prevention of diseases and in medical research.
A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.
Researchers have created a system that uses generative AI to study the shape and structure of blood cells, and spot unusual or rare cells that may indicate disease such as leukaemia.
The NanoZoomer S540MD by Hamamatsu is engineered with the lab in mind for a seamless workflow. Featuring compatibility with staining racks, fast slide scanning, exceptional image quality, and an intuitive touchscreen interface, this high-capacity scanner is built to handle the needs of the clinical pathology laboratory.
Using a bioengineered bone marrow model, researchers were able to provide key new information on the efficacy and safety of CAR T-cell therapy for acute myeloid leukaemia (AML), the most common leukaemia in adults.
Most patients with metastatic colorectal cancer do not respond to immunotherapy—but why? A new study shows how the tumours block the immune system through two complementary mechanisms.
More than a decade of protection against the human papillomavirus (HPV): a new study confirms the long-term effectiveness of the HPV vaccine to prevent development of cervical cancer and pre-cancer.
A biosensor that identifies volatile organic compounds (VOCs) in exhaled breath could be used in conjunction with AI to detect various thoracic cancers including lung cancer.
An innovative Group A Streptococcus “One-Step Antigen Extraction + Detection” Kit (immunochromatography), developed by GenSure Biotech Inc., has successfully obtained both Class B and Class C EU IVDR certifications for in vitro diagnostic medical devices.
Newly discovered blood biomarkers may offer new options to track Duchenne muscular dystrophy (DMD) in a less invasive way than physical tests or biopsies. This could support more tailored treatments.
Researchers have discovered a previously unknown mechanism that explains how bacteria within a tumor can drive treatment resistance in patients with oral and colorectal cancer.
In the NICU, a few hours can mean the difference between unnecessary procedures and targeted, life-saving treatment. A new speed record for WGS opens new diagnostic possibilities.
Scientists are on the way to finding a vaccine to fight off Helicobacter pylori - a bacterium found in over 60% of people - possibly preventing stomach ulcers and lowering the risk for stomach cancer.
Chronic fatigue (ME/CFS) affects millions worldwide, but is poorly understood and has long lacked reliable diagnostic tools. Now, a new blood test claims to diagnose the condition with 96% accuracy.
HIV manages to persist in the body for decades after infection and treatment. Now, researchers discovered that the virus cloaks itself in the DNA of infected cells using unique DNA patterns.
Researchers from the University of Birmingham’s Bladder Cancer Research Centre have found a new way of detecting tumour DNA in urine to identify bladder cancer.
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumours in some cancers.
A new study shows that a gene expression test on routinely collected prostate tissue can help guide therapy choices for prostate cancer patients whose cancer has spread to other parts of the body.
An unexpected trigger for heart attack: Researchers show that dormant bacteria can contribute to atherosclerotic plaques and fatal myocardial infarction, effectively making it an infectious disease.
As digital transformation accelerates across healthcare, AIRA Matrix stands at the forefront of artificial intelligence innovation in pathology. The company will showcase its comprehensive portfolio of AI-driven diagnostic and analytical solutions at the upcoming European Congress of Pathology in Vienna this September.
For Sakura Finetek, the ECP congress theme “Tradition meets the future” reflects who we are: a company deeply rooted in histopathology tradition, with a proud legacy of quality and reliability, yet constantly pushing boundaries to transform the future of diagnostics.
Learn how to perform CD138+ enrichment in our free, on-demand course covering sample collection, isolation, and processing. Watch expert-led 15 - 20 minute lectures and quizzes at your own pace, and earn a certificate by completing an optional final assessment.
Self-learning artificial intelligence approaches are offering a number of advantages for digital pathology when compared to established AI options. The benefits, which range from greater speed and capacitive flexibility to ‘wholly interpretable’ analyses, were outlined at the Digital Pathology and AI Congress in London.
Scientists developed an AI-based approach to diagnose colorectal cancer from different microbial subgroups in the gut microbiota – a non-invasive and low-cost alternative to colonoscopy screening.
Men assessed as healthy may still have an early form of prostate cancer. Using AI, researchers found signs that were missed in more than 80% of samples of men who later developed cancer.
New research suggests that KFRE, a common prognostic tool to predict kidney failure, could underestimate the risk for individuals with chronic kidney disease (CKD) who also have frailty.
